|
|
Biochem J. 2003 April 15; 371(Pt 2): 395–403. doi: 10.1042/BJ20021730. | PMCID: PMC1223299 |
The Fn14 cytoplasmic tail binds tumour-necrosis-factor-receptor-associated factors 1, 2, 3 and 5 and mediates nuclear factor-kappaB activation. Sharron A N Brown, Christine M Richards, Heather N Hanscom, Sheau-Line Y Feng, and Jeffrey A Winkles Vascular Biology Department, Jerome H. Holland Laboratory for the Biomedical Sciences, American Red Cross, 15601 Crabbs Branch Way, Rockville, MD 20855, USA. Fn14 is a growth-factor-inducible immediate-early-response gene encoding a 102-amino-acid type I transmembrane protein. The human Fn14 protein was recently identified as a cell-surface receptor for the tumour necrosis factor (TNF) superfamily member named TWEAK (TNF-like weak inducer of apoptosis). In the present paper, we report that the human TWEAK extracellular domain can also bind the murine Fn14 protein. Furthermore, site-specific mutagenesis and directed yeast two-hybrid interaction assays revealed that the TNFR-associated factor (TRAF) 1, 2, 3 and 5 adaptor molecules bind the murine Fn14 cytoplasmic tail at an overlapping, but non-identical, amino acid sequence motif. We also found that TWEAK treatment of quiescent NIH 3T3 cells stimulates inhibitory kappaBalpha phosphorylation and transcriptional activation of a nuclear factor-kappaB (NF-kappaB) enhancer/luciferase reporter construct. Fn14 overexpression in transiently transfected NIH 3T3 cells also promotes NF-kappaB activation, and this cellular response requires an intact TRAF binding site. These results indicate that Fn14 is a functional TWEAK receptor that can associate with four distinct TRAF family members and stimulate the NF-kappaB transcription factor signalling pathway. The Full Text of this article is available as a PDF (258K). These references are in PubMed. This may not be the complete list of references from this article. - Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001 Feb 23;104(4):487–501. [PubMed]
- Bodmer Jean-Luc, Schneider Pascal, Tschopp Jürg. The molecular architecture of the TNF superfamily. Trends Biochem Sci. 2002 Jan;27(1):19–26. [PubMed]
- Marsters SA, Sheridan JP, Pitti RM, Brush J, Goddard A, Ashkenazi A. Identification of a ligand for the death-domain-containing receptor Apo3. Curr Biol. 1998 Apr 23;8(9):525–528. [PubMed]
- Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I, Browning JL. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J Biol Chem. 1997 Dec 19;272(51):32401–32410. [PubMed]
- Schneider P, Schwenzer R, Haas E, Mühlenbeck F, Schubert G, Scheurich P, Tschopp J, Wajant H. TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur J Immunol. 1999 Jun;29(6):1785–1792. [PubMed]
- Nakayama Masafumi, Ishidoh Kazumi, Kayagaki Nobuhiko, Kojima Yuko, Yamaguchi Noriko, Nakano Hiroyasu, Kominami Eiki, Okumura Ko, Yagita Hideo. Multiple pathways of TWEAK-induced cell death. J Immunol. 2002 Jan 15;168(2):734–743. [PubMed]
- Nakayama Masafumi, Ishidoh Kazumi, Kojima Yuko, Harada Norihiro, Kominami Eiki, Okumura Ko, Yagita Hideo. Fibroblast growth factor-inducible 14 mediates multiple pathways of TWEAK-induced cell death. J Immunol. 2003 Jan 1;170(1):341–348. [PubMed]
- Lynch CN, Wang YC, Lund JK, Chen YW, Leal JA, Wiley SR. TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem. 1999 Mar 26;274(13):8455–8459. [PubMed]
- Harada Norihiro, Nakayama Masafumi, Nakano Hiroyasu, Fukuchi Yoshinosuke, Yagita Hideo, Okumura Ko. Pro-inflammatory effect of TWEAK/Fn14 interaction on human umbilical vein endothelial cells. Biochem Biophys Res Commun. 2002 Dec 6;299(3):488–493. [PubMed]
- Desplat-Jégo Sophie, Varriale Simone, Creidy Rita, Terra Rafik, Bernard Dominique, Khrestchatisky Michel, Izui Shozo, Chicheportiche Yves, Boucraut José TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity. J Neuroimmunol. 2002 Dec;133(1-2):116–123. [PubMed]
- Saas P, Boucraut J, Walker PR, Quiquerez AL, Billot M, Desplat-Jego S, Chicheportiche Y, Dietrich PY. TWEAK stimulation of astrocytes and the proinflammatory consequences. Glia. 2000 Oct;32(1):102–107. [PubMed]
- Chicheportiche Yves, Chicheportiche Rachel, Sizing Irene, Thompson Jeff, Benjamin Christopher B, Ambrose Christine, Dayer Jean-Michel. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies. Arthritis Res. 2002;4(2):126–133. [PubMed]
- Schmitz I, Kirchhoff S, Krammer PH. Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol. 2000 Nov–Dec;32(11-12):1123–1136. [PubMed]
- Inoue J i, Ishida T, Tsukamoto N, Kobayashi N, Naito A, Azuma S, Yamamoto T. Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp Cell Res. 2000 Jan 10;254(1):14–24. [PubMed]
- Wajant H, Henkler F, Scheurich P. The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal. 2001 Jun;13(6):389–400. [PubMed]
- Wiley SR, Cassiano L, Lofton T, Davis-Smith T, Winkles JA, Lindner V, Liu H, Daniel TO, Smith CA, Fanslow WC. A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. Immunity. 2001 Nov;15(5):837–846. [PubMed]
- Kaptein A, Jansen M, Dilaver G, Kitson J, Dash L, Wang E, Owen MJ, Bodmer JL, Tschopp J, Farrow SN. Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3). FEBS Lett. 2000 Nov 24;485(2-3):135–141. [PubMed]
- Migone Thi Sau, Zhang Jun, Luo Xia, Zhuang Li, Chen Cecil, Hu Bugen, Hong June S, Perry James W, Chen Su Fang, Zhou Joe X H, Cho Yun Hee, Ullrich Stephen, Kanakaraj Palanisamy, Carrell Jeffrey, Boyd Ernest, Olsen Henrik S, Hu Gang, Pukac Laurie, Liu Ding, Ni Jian, Kim Sunghee, Gentz Reiner, Feng Ping, Moore Paul A, Ruben Steve M, Wei Ping. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity. 2002 Mar;16(3):479–492. [PubMed]
- Meighan-Mantha RL, Hsu DK, Guo Y, Brown SA, Feng SL, Peifley KA, Alberts GF, Copeland NG, Gilbert DJ, Jenkins NA, Richards CM, Winkles JA. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration. J Biol Chem. 1999 Nov 12;274(46):33166–33176. [PubMed]
- Feng SL, Guo Y, Factor VM, Thorgeirsson SS, Bell DW, Testa JR, Peifley KA, Winkles JA. The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol. 2000 Apr;156(4):1253–1261. [PubMed]
- Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 1989 Apr 15;77(1):51–59. [PubMed]
- Arch RH, Thompson CB. 4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor kappaB. Mol Cell Biol. 1998 Jan;18(1):558–565. [PubMed]
- Duckett CS, Thompson CB. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 1997 Nov 1;11(21):2810–2821. [PubMed]
- Kolodziej PA, Young RA. Epitope tagging and protein surveillance. Methods Enzymol. 1991;194:508–519. [PubMed]
- Ye H, Park YC, Kreishman M, Kieff E, Wu H. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell. 1999 Sep;4(3):321–330. [PubMed]
- Park YC, Burkitt V, Villa AR, Tong L, Wu H. Structural basis for self-association and receptor recognition of human TRAF2. Nature. 1999 Apr 8;398(6727):533–538. [PubMed]
- Baker SJ, Reddy EP. Modulation of life and death by the TNF receptor superfamily. Oncogene. 1998 Dec 24;17(25):3261–3270. [PubMed]
- Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000;18:621–663. [PubMed]
- Ghosh Sankar, Karin Michael. Missing pieces in the NF-kappaB puzzle. Cell. 2002 Apr;109(Suppl):S81–S96. [PubMed]
- Krajewska M, Krajewski S, Zapata JM, Van Arsdale T, Gascoyne RD, Berern K, McFadden D, Shabaik A, Hugh J, Reynolds A, Clevenger CV, Reed JC. TRAF-4 expression in epithelial progenitor cells. Analysis in normal adult, fetal, and tumor tissues. Am J Pathol. 1998 Jun;152(6):1549–1561. [PubMed]
- Ye X, Mehlen P, Rabizadeh S, VanArsdale T, Zhang H, Shin H, Wang JJ, Leo E, Zapata J, Hauser CA, Reed JC, Bredesen DE. TRAF family proteins interact with the common neurotrophin receptor and modulate apoptosis induction. J Biol Chem. 1999 Oct 15;274(42):30202–30208. [PubMed]
- Ye Hong, Arron Joseph R, Lamothe Betty, Cirilli Maurizio, Kobayashi Takashi, Shevde Nirupama K, Segal Deena, Dzivenu Oki K, Vologodskaia Masha, Yim Mijung, Du Khoi, Singh Sujay, Pike J Wesley, Darnay Bryant G, Choi Yongwon, Wu Hao. Distinct molecular mechanism for initiating TRAF6 signalling. Nature. 2002 Jul 25;418(6896):443–447. [PubMed]
- Pullen SS, Dang TT, Crute JJ, Kehry MR. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs. J Biol Chem. 1999 May 14;274(20):14246–14254. [PubMed]
- Hsu H, Solovyev I, Colombero A, Elliott R, Kelley M, Boyle WJ. ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J Biol Chem. 1997 May 23;272(21):13471–13474. [PubMed]
- Jang IK, Lee ZH, Kim YJ, Kim SH, Kwon BS. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. Biochem Biophys Res Commun. 1998 Jan 26;242(3):613–620. [PubMed]
- Galibert L, Tometsko ME, Anderson DM, Cosman D, Dougall WC. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J Biol Chem. 1998 Dec 18;273(51):34120–34127. [PubMed]
- Boucher LM, Marengère LE, Lu Y, Thukral S, Mak TW. Binding sites of cytoplasmic effectors TRAF1, 2, and 3 on CD30 and other members of the TNF receptor superfamily. Biochem Biophys Res Commun. 1997 Apr 28;233(3):592–600. [PubMed]
- Hu HM, O'Rourke K, Boguski MS, Dixit VM. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem. 1994 Dec 2;269(48):30069–30072. [PubMed]
- Ishida TK, Tojo T, Aoki T, Kobayashi N, Ohishi T, Watanabe T, Yamamoto T, Inoue J. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9437–9442. [PubMed]
- Pullen SS, Miller HG, Everdeen DS, Dang TT, Crute JJ, Kehry MR. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry. 1998 Aug 25;37(34):11836–11845. [PubMed]
- Lee HH, Dempsey PW, Parks TP, Zhu X, Baltimore D, Cheng G. Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation. Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1421–1426. [PubMed]
- Leo E, Welsh K, Matsuzawa S, Zapata JM, Kitada S, Mitchell RS, Ely KR, Reed JC. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation. J Biol Chem. 1999 Aug 6;274(32):22414–22422. [PubMed]
- McWhirter SM, Pullen SS, Holton JM, Crute JJ, Kehry MR, Alber T. Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8408–8413. [PubMed]
- Ni CZ, Welsh K, Leo E, Chiou CK, Wu H, Reed JC, Ely KR. Molecular basis for CD40 signaling mediated by TRAF3. Proc Natl Acad Sci U S A. 2000 Sep 12;97(19):10395–10399. [PubMed]
- Griffioen AW, Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol Rev. 2000 Jun;52(2):237–268. [PubMed]
|
This article has been